Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 5/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL933476 | 0.90 | KDM1A (0.38) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL28164961 | 0.86 | KDM1A (0.40) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL23085581 | 0.86 | KDM1A (0.40) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL19457103 | 0.85 | — | — | |
| SCHEMBL12632397 | 0.85 | — | — | |
| SCHEMBL5752748 | 0.85 | — | — | |
| SCHEMBL14899968 | 0.83 | KDM1A (0.35) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL14823372 | 0.73 | CHRM5 (0.38) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL5389995 | 0.72 | CHRM5 (0.33) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL6047335 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102702841-B | Gallium formulated ink and methods of making and using same | ROHM & HAAS ELECT MAT | 2015-01-14 | — | — | CN | claimed |
| CN-102643570-B | Gallium ink and methods of making and using same | ROHM AND HAAS ELECTRONIC MATERIALS CO., LTD. (US) | 2014-10-29 | — | — | CN | claimed |
| CN-102702841-A | Gallium formulated ink and methods of making and using same | ROHM & HAAS ELECT MAT | 2012-10-03 | — | — | CN | claimed |
| CN-102643570-A | Gallium ink and methods of making and using same | ROHM & HAAS ELECT MAT | 2012-08-22 | — | — | CN | claimed |
| CN-102702841-B | Gallium formulated ink and methods of making and using same | ROHM & HAAS ELECT MAT | 2015-01-14 | — | — | CN | disclosed |
| CN-102643570-B | Gallium ink and methods of making and using same | ROHM AND HAAS ELECTRONIC MATERIALS CO., LTD. (US) | 2014-10-29 | — | — | CN | disclosed |
| CN-101503409-B | 8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments | BOEHRINGER INGELHEIM PHARMA | 2014-01-22 | — | — | CN | disclosed |
| CN-101503408-B | 8-(3-amino-piperidin-1-yl)-xanthines | BEOEHRINGER INGELHEIM PHARMA GMBH & CO KG | 2013-04-24 | — | — | CN | disclosed |
| CN-102964347-A | 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments | BOEHRINGER INGELHEIM PHARMA | 2013-03-13 | — | — | CN | disclosed |
| CN-102702841-A | Gallium formulated ink and methods of making and using same | ROHM & HAAS ELECT MAT | 2012-10-03 | — | — | CN | disclosed |
| CN-102643570-A | Gallium ink and methods of making and using same | ROHM & HAAS ELECT MAT | 2012-08-22 | — | — | CN | disclosed |
| CN-102234341-A | Components and catalysts for the polymerization of olefins | SUMITOMO CHEMICAL CO | 2011-11-09 | — | — | CN | disclosed |
| CN-101553573-A | Whole-cell catalytic system comprising a hydantoinase, a racemase and a carbamoylase | DSM IP ASSETS BV (NL) | 2009-10-07 | — | — | CN | disclosed |
| CN-101503408-A | 8-(3-amino-piperidin-1-yl)-xanthines | BOEHRINGER INGELHEIM PHARMA (DE) | 2009-08-12 | — | — | CN | disclosed |
| CN-101503409-A | 8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments | BOEHRINGER INGELHEIM PHARMA (DE) | 2009-08-12 | — | — | CN | disclosed |
| CN-100522962-C | 8- [ 3-amino-piperidin-1-yl ] -xanthines, process for their preparation and their use as pharmaceutical preparations | BOEHRINGER INGELHEIM PHARMA (DE) | 2009-08-05 | — | — | CN | disclosed |
| CN-1675212-A | 8- [ 3-amino-piperidin-1-yl ] -xanthines, process for their preparation and their use as pharmaceutical preparations | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-09-28 | — | — | CN | disclosed |
| CN-1440409-A | Polycyclic compounds as inhibitors of PARP, VEGFR2 and MLK3 enzymes and uses | CEPHALON INC (US) | 2003-09-03 | — | — | CN | disclosed |
| CN-1040105-C | Aminoketone derivatives and use thereof | MITZUI TOATSU CHEMICALS INC (JP) | 1998-10-07 | — | — | CN | disclosed |
| CN-1049660-A | Aminoketone derivative and application thereof | MITZUI TOATSU CHEMICALS INC (JP) | 1991-03-06 | — | — | CN | disclosed |